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ABSTRACT 
Objective: The aim of formulating floating tablets of ciprofloxacin hydrochloride was to prolong the gastric residence time after oral administration 
to achieve the controlled release of drug. Ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone antibacterial agent and it is use in the 
treatment of bone and joint infections, diarrhoeal infection, lower respiratory tract infections, urinary tract infections and meningococcal 
prophylaxis.  
Methods: Floating tablets of Ciprofloxacin hydrochloride were prepared by wet granulation method using two different grades (K-100M & K-4M) of 
Hydroxyl Propyl Methyl Cellulose (HPMC) and Carbopol 934P using effervescent technique. Sodium bicarbonate was incorporated as a gas-
generating agent. The floating tablets were evaluated for uniformity of weight, hardness, friability, drug content, in vitro buoyancy and dissolution 
studies. The effect of citric acid on drug release profile and floating properties was also investigated. 
Results: It was observed that tablet swelled radially and axially during in vitro buoyancy studies and remained buoyant for 10-14 h. The 
combination of sodium bicarbonate (70 mg) and citric acid (20 mg) was found to achieve the optimum in vitro buoyancy. 
Conclusion: In the present work it was concluded that the floating duration of was more in tablet with HPMC K-100 as compared with formulations 
containing HPMC K-4M. Drug ciprofloxacin hydrochloride release could be prolonged about 14 h in the GIT by using blend of HPMC-K 100M with 
sodium bicarbonate as gas generating agent and formulate it as a gastro retentive floating tablet.  
Keywords: Floating lag time, Ciprofloxacin hydrochloride, Total floating time, Hydroxyl Propyl Methyl Cellulose 
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INTRODUCTION 
Gastro retentive drug delivery is an approach to prolong gastric 
residence time of the drug by floating the dosage form and thereby 
targeting site-specific drug release in the upper gastrointestinal tract 
(GIT) for local or systemic effects [1, 2]. Floating drug delivery 
systems (FDDS) is one of the important approaches to enhance 
gastric retention of the drug for better drug bioavailability [3]. FDDS 
is desirable for drugs having absorption window in the stomach or 
in the upper small intestine [4]. The FDDS should have a bulk 
density less than gastric fluids to remain buoyant in the stomach 
without affecting gastric emptying rate for a prolonged period and 
the drug is released slowly at a desired and controlled rate from the 
system. After the release of the drug, the residual system is emptied 
from the stomach. This floating drug release result in an increased 
gastric retention time (GRT) and a better control of the 
concentration drug fluctuation in blood plasma.  
Ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone 
antibacterial agent. It is approved for use in the treatment of bone 
and joint infections, infectious diarrhea, lower respiratory tract 
infections, urinary tract infections, hospital-acquired infections and 
meningococcal prophylaxis [5]. Since the drug is freely soluble in 
water (1 g in 25 ml) and has an elimination half-life of about 4 h 
which is suitable to make a sustained-release dosage form aiming to 
enhance its antibacterial activity and provide a constant release of 
the drug without much fluctuation of plasma drug concentration in 
the blood. For the present study ciprofloxacin hydrochloride was 
selected due to broad spectrum and effective antibacterial agent and 
a drug of choice in various infections, as per the BCS classification 
ciprofloxacin hydrochloride is class 3 drug which is highly soluble 
and make it suitable for gastro restive floating purpose and HPMC K-
100 was used as polymer because of better-floating capacity. 
The aim of this study was to get better drug release with less 
fluctuation of plasma drug concentration of ciprofloxacin 
hydrochloride to the stomach, and the proximal parts of the small 
intestine floating tablet were prepared as compared to available 
dosage form and the drug release up to 12 hours with less 
fluctuation. This gastro retentive floating tablet increases the mean 
residence time (MRT) in the stomach and prolong the gastric 
emptying that provides the maximum drug at the site of absorption. 
Low viscosity hydrophilic polymer HPMC K-100 was found to be 
more beneficial to improving floating properties. The low 
concentration of hydrophilic polymer slowly forms a thick gel, which 
retains the integrity of the formulation and promotes drug release 
through thick gel which controls the burst release [6, 7]. The novelty 
of this work is prolonged release the drug (about 14 h) with less 
fluctuation and using less viscous polymer. 
MATERIALS AND METHODS 
Ciprofloxacin HCl was received as a gift sample from Mars Remedies 
Pvt. Ltd. Vadodara, India. Hydroxypropyl methyl cellulose K-100M 
(HPMC K-100M) was obtained from Vishal Pharma, Vadodara, India 
and Carbopol 934P was received as a gift sample from Corel Pharma, 
Ahmedabad, India. Sodium bicarbonate and citric acid were 
purchased from Suvidhinath Laboratory and Harsh Pharma, 
Vadodara, India respectively. 
Pre-compression parameters  
Bulk density 
Powder bulk density was determined by USP bulk density apparatus 
(Electrolab). It was measured by pouring the weighed granules into 
a measuring cylinder, and the volume was noted. It is expressed in 
gm/ml and is given by  
Db= M/V0 
Where, M is the mass of powder, V0 is the bulk volume of the 
powder  
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Tapped density 
The tapped density was measured USP bulk density apparatus 
(Electrolab) by tapping the drug granules of fixed mass for 50 and 
then 100 tapped until it reached a constant volume. It is expressed 
in gm/ml and is given by 
DT= M/VT 
Where, M is the mass of powder, VT is the tapped volume of the 
powder  
Carr’s index 
It is also known as % compressibility, and it was determined on the 
basis of bulk and tapped density data and given by 
Carr’s Index = (Tapped density-Bulk density)/Tapped density X 100 
Hausner’s ratio 
It was calculated on the basis of bulk and tapped density data and 
given by 
Tapped density/bulk density 
Preparation of floating matrix tablet 
Different tablet formulations (table 1) were prepared by wet 
granulation technique. The required quantity of drug, polymer and 
filler were passed through 40 number sieves. The required quantity 
of PVP K-30 was dissolved in Isopropyl alcohol (IPA) to prepare a 
binder solution. The binder solution was added to the dry blend with 
constant kneading to form a homogeneous mass. After enough 
cohesiveness had been obtained, the granules were allowed to dry at 
50°C for 15 min. Then granules were passed through 20 number 
sieves. Talc and magnesium stearate were finally added as glidant 
and lubricant respectively. The granules were compressed using 
double rotary tablet compression machine (Cad mach, India CMB4–
35 stations) [8-11].  
In order to evaluate the best matrix forming a polymer, different 
formulations of floating tablets were prepared by using HPMC K-4M 
(batches C1-C3), HPMC K-100M (batches C4-C6), Carbopol 934P 
(batches C7-C9), in 100, 125 and 150 mg amount and these were 
evaluated.
  



















Ciprofloxacin HCl 582 582 582 582 582 582 582 582 582 
HPMC K-4M 100 125 150 - - - - - - 
HPMC K-100M - - - 100 125 150 - - - 
Carbopol-934P - - - - - - 100 125 150 
Sodium bicarbonate 75 75 75 75 75 75 75 75 75 
Citric acid 20 20 20 20 20 20 20 20 20 
PVP-K30 15 15 15 15 15 15 15 15 15 
Isopropyl alcohol q. s. q. s. q. s. q. s. q. s. q. s. q. s. q. s. q. s. 
Lactose 94 69 44 94 69 44 94 69 44 
Magnesium stearate 7 7 7 7 7 7 7 7 7 
Talc 7 7 7 7 7 7 7 7 7 
Total wt. 900 900 900 900 900 900 900 900 900 
q. s.= Quantity sufficient, C1-C9 is the formulation codes 
 
Post-compression parameters 
Weight variation test 
Randomly twenty tablets of the formulation were selected and 
weighed using a Sartorius electronic balance and the test was 
performed according to the Indian Pharmacopoeia official method. 
Determinations were made in triplicate. 
Hardness 
The hardness of five tablets was determined using the Monsanto 
hardness tester and the average values were calculated. 
Determinations were made in triplicate. 
Friability 
The friability of the tablets was measured in a Roche friabilator. 








). After 100 
revolutions (speed-25 RPM), the sample of 20 tablets was de-dusted 
and weighed (W) again. Percentage friability was calculated from 
the loss in weight as per the given in equation below. 
Determinations were made in triplicate. 
 
Drug assay 
Ten tablets were individually weighed and crushed. A quantity of 
powder equivalent to the mass of one tablet (900 mg) was extracted 
in 100 ml of 0.1N HCl. The solution was filtered through 0.45µ 
membrane. The drug content was determined by UV-Visible 
Spectrophotometer (Shimadzu UV-1800) at a wavelength of 276 nm 
after making suitable dilution with 0.1 N HCl [12].  
In-vitro buoyancy study 
The in vitro buoyancy was determined by floating lag time method 
[13]. The tablets were placed in 100 ml beaker containing 0.1 N HCl. 
The time required for the tablets to rise to the surface and float was 
determined as floating lag time. 
In-vitro dissolution studies 
The release rate of ciprofloxacin hydrochloride from floating tablets 
was determined using The United States Pharmacopoeia (USP) 
dissolution testing apparatus II (paddle method). The dissolution 
test was performed using 900 ml of 0.1 N HCl, at 37 °C and 50 RPM. 
A sample (10 ml) of the solution was withdrawn from the 
dissolution apparatus at an interval of 1, 2, 3, 4, 6, 8, 10, 12, 14 h and 
the samples were replaced with fresh dissolution medium 
maintained at 37 °C. The samples were filtered through a 0.45 µ 
membrane filter and diluted to a suitable concentration with 0.1N 
HCl. The absorbance of these solutions was measured at 276 nm 
using UV-Visible Spectrophotometer (Shimadzu UV-1800). 
Cumulative percentage of drug release was calculated using the 
equation obtained from a standard curve [14-18]. 
Accelerated stability study 
Ciprofloxacin hydrochloride gastro retentive tablets of batch C4 
were packed in blister packing, and this packed tablet was kept for 
three months for the accelerated stability study at 40 °C and 75% RH. 
Periodically (0, 1, 2 and 3 mo interval) samples were removed and 
characterized by in-vitro drug release study and floating lag time. 
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RESULTS 
The result of pre-compression parameters for the ciprofloxacin 
granules was recorded in table 2 and it was found that the angle of 
repose of all batches except C8 is less than 30 °. The bulk density of 
powder blend was found in the range of 0.1486-0.1683 g/ml. The 
value Carr’s index was in the range of 14.68-18.86 and Hausner’s 
ratio was in the range of 1.17-1.23. 
 
Table 2: Flow properties of ciprofloxacin HCl powder blend 
Batch Loose bulk density (g/ml) Tapped bulk density (g/ml) Carr’s index (%) Hausner’s ratio Angle of repose (θ) 
C 0.1660 1 0.1990 16.55 1.19 29.68 
C 0.1584 2 0.1866 15.13 1.17 28.34 
C 0.1616 3 0.1957 17.44 1.21 28.67 
C 0.1563 4 0.1838 14.93 1.17 27.68 
C 0.1486 5 0.1783 16.66 1.20 28.01 
C 0.1514 6 0.1866 18.86 1.23 25.98 
C 0.1649 7 0.1990 17.12 1.20 29.68 
C 0.1594 8 0.1957 18.54 1.22 30.13 
C 0.1683 9 0.1973 14.68 1.17 28.56 
*n=3, Average of three determinations for loose bulk density, tapped bulk density, angle of repose, carr’s index and hausner’s ratio 
 
The pre-compression parameters like angle of repose of all batches 
is less than 30 ° which shows that powder blend had good flow and 
suitable for tablet compression as well as the Carr’s index values are 
in the range of good flow and all these shows that powder blend is 
good for tablet compression. 
The post-compression parameters like weight variation test, 
hardness, friability, drug assay, in-vitro buoyancy study (floating 
time and floating leg time) data of batches C1 to C9 were recorded in 
table 3. The variation weight results varies between 899.6–904 mg, 
the hardness was found between 4.1 to 5.1 kg/cm2
The floating leg time varies between 39-66 s and floating time 
varies between 10-14 h. When floating times was compared, it 
was found that C
, the friability of 
all batches were less than 1% and the drug assay of all batches were 
remained in the range 90-110%. The results of post-compression 
parameters (quality control evaluation) of a powder blend of all the 
formulation batches (C1-C9) were under the pharmacopeial limits 
which show that formulation development is good for further 
reproduction.  
4,  C 5,  C 6  having 14 h which is good for 
prolongation of drug release so on the basis of drug assay and 
floating time C 4  and C 6
 
 batches were good and selected as 
optimum batches. 
Table 3: Post compression evaluation of ciprofloxacin HCl tablet 
Batch Avg. weight  % Friability Hardness (kg/cm2 Drug assay (%) )  Floating lag time (s) Floating time(h) 
C 901.1±4.19 1 0.442±0.004 4.1±0.12 98.2±2.9 35±0.943 10±0.029 
C 903.5±5.548 2 0.551±0.017 4.4±0.05 101.6±2.6 41±0.471 12±0.081 
C 904±5.160 3 0.495±0.021 5.0±0.15 94.8±1.8 39±0.471 12±0.061 
C 902.2±5.125 4 0.444±0.016 4.5±0.43 101.3±1.9 47±1.414 14±0.032 
C 901.65±5.733 5 0.386±0.012 4.4±0.05 98±3.1 42±0.943 14±0.043 
C 900±4.180 6 0.605±0.043 5.0±0.15 101.1±1.9 49±0.942 14±0.067 
C 901.65±5.527 7 0.663±0.020 4.9±0.19 96.6±2.3 62±0.816 12±0.069 
C 900.6±4.816 8 0.606±0.016 4.8±0.09 98.4±2.7 59±0.471 13±0.035 
C 899.6±5.164 9 0.549±0.022 5.1±0.21 98.4±1.4 66±0.943 13±0.071 
*n=3, Average of three determinations for hardness, floating leg time, floating time Water absorption ratio, drug assay, friability, weight variation 
n=20. Sample size for friability and weight variation was 20 
 
Table 4: In-vitro drug release study of ciprofloxacin HCl tablets from different batches 
Time (h) Cumulative % drug release 
C C1 C2 C3 C4 C5 C6 C7 C8 9 
0 0 0 0 0 0 0 0 0 0 
1 21.10 19.20 17.20 21.30 13.90 12.10 10.10 9.10 7.60 
2 39.20 23.40 24.60 23.80 16.00 18.20 18.00 16.00 14.10 
3 46.10 29.10 35.10 29.20 20.20 25.12 26.32 21.45 19.30 
4 58.40 34.20 44.20 31.14 25.30 29.10 32.57 28.14 26.34 
6 68.30 41.20 49.20 39.50 33.26 35.10 39.00 33.65 31.40 
8 80.00 55.50 57.90 48.90 45.30 40.20 42.13 38.00 34.30 
10 100.20 88.00 87.40 64.00 69.30 64.00 54.64 53.36 54.28 
12 - 90.70 89.30 81.70 73.10 80.20 65.00 61.03 62.10 
14 - -  98.50 89.10 86.14 75.23 73.13 70.41 
* n=3, Average of three determinations  
 
The floating leg time varies between 39-66 s and floating time is up 
to 14 h both are significantly good for floating drug delivery system 
as well as better as compare to other available formulations [19]. 
The floating tablet will be retain in the GIT for the long time (about 
14 Hour) with less drug plasma concentration fluctuation and 
deliver the drug for prolong period.  
The In-vitro dissolution study of all batches (C1-C9) was performed 
in 0.1 N HCl and the data were recorded in the table 4. The batch C1  
released 100.2% of drug but the entire drug is released in 10 hour 
whereas in the case of batch C4 of 98.5 % drug release in 14 h which 
is good for prolongation of drug release means tablet will be float for 
14 h and will release the drug in controlled manner so batch C4 was 
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selected as an optimum batch for the stability study to confirm the 
stability of the floating tablet of ciprofloxacin hydrochloride. 
 
Fig. 1: In-vitro drug release of ciprofloxacin HCl tablets from 
different batches 
** n=3, Average of three determinations 
 
The drug release from the all the formulation batches varies 
between 70-100 % and out of which batch C4 was selected as an 
optimized batch because as per the requirement for better release as 
compared to other available research [19] this batch releases the 
drug about 100% and up to 14 h which indicated long floating with 
less plasma drug concentration fluctuations.  
Tablets containing different matrix forming agents (HPMC K-4M, 
HPMC K-100M and Carbopol 934 P) were prepared as per the 
formulation composition is given in table 1. The batches coded as C1 
to C9
The concentration of HPMC K-100 M was 13.88% in the optimum 
powder blend which can float the tablet for 14 h. The effect of 
different concentration of sodium bicarbonate was checked, and the 
concentration was optimized to 8.33 %. Batch C
 having 100, 125, 150 mg of HPMC K-4M, HPMC K-100M, and 
carbopol 934P respectively.  In the case of HPMC K-4M, tablet 
prepared by using 100 mg of polymer almost 100% drug release at 
10h whereas in 125 and 150 mg of polymer, 90% of drug release 
within 12 h but it fail to retard drug release after 12 h and the tablet 
loss its integrity. In the case of HPMC K-100M, 98.5 % of drug 
release at 14 h when the polymer is 100 mg, and the tablet retains 
its integrity whereas with carbopol 934P the drug release rate was 
found more retarded and carbopol has a negative effect on floating.  
4
In the formulations it was observed that carbopol has a high affinity 
towards water and promotes water penetration into tablet matrices 
increases the density which ultimately decrease the floating time 
that is not suitable for floating tablet so the formulation batches 
those are having carbopol were excluded, and only the formulation 
which is having HPMC K-100M with 100 mg polymer (13.88%) was 
selected for further study. The optimized formulation batch (C4) 
which is having floating time around 14 h and releases drug about 
98 % gives a clear indication about the good formula for better 
floating in the GIT. The accelerated stability study of optimizing 
batch C4 was conducted, and the In-vitro drug release study data 
were recorded in table 5 and expressed by fig. 2. The floating leg 
time data were recorded in table 6. 
 with 8.33 % of 
sodium bicarbonate shows a floating lag time of 47 s, floating time of 
14 h and drug release up to 98.5% all these results show that batch 
C4 is good because it is having good floating time and release the 
drug for a long time. After optimization, the formulation was kept for 
stability study.  
 
 
Fig. 2: In-vitro drug release study of ciprofloxacin HCl tablets 
from batch C4 (stability study batch) 
** n=3, Average of three determinations 
  
Table 5: In-vitro drug release study of ciprofloxacin HCl tablets from batch C4 (stability study batch) 
Time (h) Outer appearance Cumulative % drug release 
Initial sample 1 Mo sample 2 Mo sample 3 Mo sample 
0 White tablet 0 0 0 0 
1 White tablet 21.30 21.10 20.80 20.10 
2 White tablet 23.80 23.40 23.10 22.50 
3 White tablet 27.20 27.20 26.50 26.10 
4 White tablet 30.10 29.20 29.20 28.70 
6 White tablet 39.40 39.10 38.40 38.40 
8 White tablet 48.90 48.20 48.10 48.10 
10 White tablet 64.00 64.10 64.10 63.60 
12 White tablet 81.70 80.30 79.30 79.30 
14 White tablet 98.10 97.50 96.30 95.80 
* n=3, Average of three determinations  
 
Table 6: Floating leg time of batch C4 tablets (stability study) 
Time duration Floating leg time (s) 
Initial 47 
1 Mo 49 
2 Mo 50 
3 Mo 53 
 *n=3, Average of three determinations 
 
The in-vitro drug release profile of stability batches are same (about 
98%) as compared to before stability which indicates that there was 
no significant change in the dissolution profile which proves the 
reproducibility and stability of the formulation. 
CONCLUSION 
This research was concluded that drug ciprofloxacin hydrochloride 
release could be prolonged in the GIT by using a blend of HPMC-K 
100M with sodium bicarbonate as gas generating agent and 
formulate it as a gastro-retentive floating tablet. This formulation 
could provide desired floating lag time and floating time along with 
the good drug release profile.  
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